Ecron Acunova teams up with Essential CRO and Biotrial

By Gareth Macdonald

- Last updated on GMT

Related tags Contract research organization

Ecron Acunova’s global partnering team had a busy end to July with the Indian CRO entering into collaboration deals on both sides of the Atlantic to further expand its global reach.

In the US, the Bangalore contract research organisation (CRO) has partnered with trial and recruitment firm Essential CRO, while in France it has teamed up with first-in-man specialist Biotrial.

Ecron and Essential have worked together for some time, landing a number of “eight figure” contracts with large pharmaceutical and biotechnology firms over the last six months.

These projects, as well as the obvious operational synergies and approach to trials that the firms share, played a big part in the decision to team up according to Ecron founder D Prasanna.

Prasanna explained that: “Essential’s therapeutic database of over 4,500 studies makes its feasibility truly unique, and its global patient recruitment expertise has unmatched results.”

He suggested that this expertise, coupled with Ecron’s PK/PD, central lab and biometric services, would have considerable speed and efficacy benefits for both firms’ clients, particularly in early drug development.

Lee Jones, Essential’s CEO, also stressed the time benefits the partnership will provide for customers.

Our combined size of 350 employees and corporate cultures of fast, focused, friendly and flexible relationship management ensure that the alliance maintains the ability to meet unique sponsor needs in a timely manner.”

Biotrial deal

While at an earlier stage than the Essential accord, Ecron’s deal with Rennes-based CRO Biotrial is also a significant expansion of the Indian firm’s presence in key global research markets.

The partnership, reported by the Pharmabiz​ website last Friday, will focus on early phase clinical development, although the specifics of the collaboration have not yet been revealed.

Related news

Show more

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Related suppliers

Follow us


View more